Who Holds Ultragenyx Pharmaceutical Inc. (RARE)? 310 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 310 holders, $3.4 billion in total.
Largest holders
The 100 largest by value. Change in shares against Q1 2026.
New positions
4 managers4 managers opened a position, the largest by value MPM BIOIMPACT LLC.
Added
53 managers53 managers added shares, the largest by value BlackRock, Inc..
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| BlackRock, Inc. | 10,654,276 | $356 million | +46% | 13F |
| RTW INVESTMENTS, LP | 7,796,895 | $260 million | +114% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,790,135 | $227 million | +26% | 13F |
| AQR CAPITAL MANAGEMENT LLC | 6,560,809 | $214 million | +43% | 13F |
| STATE STREET CORP | 6,158,766 | $206 million | +23% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,296,491 | $143 million | +3% | 13F |
| TWO SIGMA INVESTMENTS, LP | 3,621,200 | $121 million | +64% | 13F |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,939,719 | $98 million | +105% | 13F |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,847,936 | $95 million | +30% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 2,578,828 | $86 million | +39% | 13F |
43 more in Added
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 1,730,193 | $58 million | +37% | 13F |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,580,000 | $53 million | +229% | 13F |
| BANK OF AMERICA CORP /DE/ | 1,148,454 | $38 million | +10% | 13F |
| Jefferies Financial Group Inc. | 929,626 | $31 million | +5902% | 13F |
| NORTHERN TRUST CORP | 920,314 | $31 million | +72% | 13F |
| Russell Investments Group, Ltd. | 784,099 | $26 million | +95% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 760,039 | $25 million | +36% | 13F |
| Nuveen, LLC | 693,959 | $23 million | +5% | 13F |
| Pictet Asset Management Holding SA | 753,695 | $23 million | +25% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 671,411 | $22 million | +10% | 13F |
| FMR LLC | 576,849 | $19 million | +101% | 13F |
| GOLDMAN SACHS GROUP INC | 575,338 | $19 million | +63% | 13F |
| Trexquant Investment LP | 556,385 | $19 million | +43% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 498,167 | $17 million | +2% | 13F |
| Bank of New York Mellon Corp | 470,697 | $16 million | +38% | 13F |
| JPMORGAN CHASE & CO | 493,126 | $15 million | +101% | 13F |
| TORONTO DOMINION BANK | 415,000 | $14 million | +256073% | 13F |
| SummitTX Capital, L.P. | 374,270 | $12 million | +8% | 13F |
| Walleye Capital LLC | 334,854 | $11 million | +180% | 13F |
| FRANKLIN RESOURCES INC | 315,766 | $11 million | +1% | 13F |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 297,819 | $10 million | +64% | 13F |
| Ensign Peak Advisors, Inc | 290,818 | $10 million | +4227% | 13F |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 272,882 | $9 million | +5% | 13F |
| Quantinno Capital Management LP | 250,466 | $8 million | +34% | 13F |
| WORLDQUANT MILLENNIUM ADVISORS LLC | 214,374 | $7 million | +42% | 13F |
| SEI INVESTMENTS CO | 211,833 | $7 million | +130% | 13F |
| Ishara Investments LP | 205,000 | $7 million | +18% | 13F |
| FIFTH THIRD BANCORP | 193,236 | $6 million | +75% | 13F |
| Atom Investors LP | 171,771 | $6 million | +83% | 13F |
| DEUTSCHE BANK AG\ | 164,813 | $6 million | +129% | 13F |
| MARSHALL WACE, LLP | 159,889 | $5 million | +2% | 13F |
| WELLS FARGO & COMPANY/MN | 157,643 | $5 million | +129% | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 156,612 | $5 million | +10% | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 156,809 | $5 million | +119% | 13F |
| Eversept Partners, LP | 154,130 | $5 million | +146% | 13F |
| Corient Private Wealth LP | 146,493 | $5 million | +7% | 13F |
| Mariner, LLC | 146,400 | $5 million | +139% | 13F |
| PINNACLE ASSOCIATES LTD | 131,104 | $4 million | +28% | 13F |
| Caption Management, LLC | 130,000 | $4 million | +18% | 13F |
| RHUMBLINE ADVISERS | 124,125 | $4 million | +20% | 13F |
| Odyssean, LLC | 122,087 | $4 million | +81% | 13F |
| IEQ CAPITAL, LLC | 106,026 | $4 million | +303% | 13F |
| Cerity Partners LLC | 105,055 | $4 million | +229% | 13F |
Cut
37 managers37 managers cut their position, the largest by value SANDS CAPITAL MANAGEMENT, LLC.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| SANDS CAPITAL MANAGEMENT, LLC | 3,158,368 | $105 million | -2% | 13F |
| Bellevue Group AG | 1,982,775 | $66 million | -17% | 13F |
| Sofinnova Investments, Inc. | 1,717,505 | $57 million | -45% | 13F |
| MORGAN STANLEY | 1,324,805 | $44 million | -12% | 13F |
| WELLINGTON MANAGEMENT GROUP LLP | 1,250,464 | $42 million | -53% | 13F |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,241,556 | $41 million | -13% | 13F |
| Candriam S.C.A. | 1,001,841 | $33 million | -9% | 13F |
| Rock Springs Capital Management LP | 967,855 | $32 million | -21% | 13F |
| Qube Research & Technologies Ltd | 882,219 | $29 million | -4% | 13F |
| MILLENNIUM MANAGEMENT LLC | 760,825 | $25 million | -57% | 13F |
27 more in Cut
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| UBS Group AG | 657,699 | $22 million | -21% | 13F |
| SPHERA FUNDS MANAGEMENT LTD. | 588,494 | $20 million | -27% | 13F |
| Legal & General Group Plc | 586,520 | $20 million | -1% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 413,700 | $14 million | -26% | 13F |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 409,255 | $14 million | -2% | 13F |
| ALGERT GLOBAL LLC | 389,964 | $13 million | -9% | 13F |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 381,420 | $13 million | -15% | 13F |
| Privium Fund Management B.V. | 338,800 | $11 million | -7% | 13F |
| Squarepoint Ops LLC | 338,368 | $11 million | -24% | 13F |
| Catalio Capital Management, LP | 316,252 | $11 million | -63% | 13F |
| CITIGROUP INC | 298,785 | $10 million | -5% | 13F |
| Jump Financial, LLC | 286,952 | $10 million | -43% | 13F |
| Invesco Ltd. | 250,533 | $8 million | -13% | 13F |
| KENNEDY CAPITAL MANAGEMENT LLC | 215,997 | $7 million | -2% | 13F |
| CITADEL ADVISORS LLC | 210,531 | $7 million | -90% | 13F |
| Man Group plc | 195,110 | $7 million | -9% | 13F |
| Connor, Clark & Lunn Investment Management Ltd. | 191,578 | $6 million | -62% | 13F |
| Blue Owl Capital Holdings LP | 182,638 | $6 million | -40% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 180,871 | $6 million | -66% | 13F |
| Swiss National Bank | 167,652 | $6 million | -2% | 13F |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 167,226 | $6 million | -25% | 13F |
| Ikarian Capital, LLC | 165,617 | $6 million | -66% | 13F |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 172,086 | $5 million | -4% | 13F |
| BARCLAYS PLC | 154,876 | $5 million | -38% | 13F |
| FRED ALGER MANAGEMENT, LLC | 143,155 | $5 million | -52% | 13F |
| MOORE CAPITAL MANAGEMENT, LP | 128,035 | $4 million | -19% | 13F |
| Assenagon Asset Management S.A. | 120,864 | $4 million | -95% | 13F |
Unchanged
6 managers6 managers held the same number of shares, the largest by value Eagle Health Investments LP.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Eagle Health Investments LP | 884,121 | $30 million | +0% | 13F |
| Palo Alto Investors LP | 596,495 | $20 million | +0% | 13F |
| GordonMD Global Investments LP | 289,101 | $10 million | +0% | 13F |
| Woodline Partners LP | 171,805 | $6 million | +0% | 13F |
| SR One Capital Management, LP | 137,753 | $5 million | +0% | 13F |
| B Group, Inc. | 135,000 | $5 million | +0% | 13F |
Questions and answers
- How many institutions hold Ultragenyx Pharmaceutical Inc.?
- 310 managers reported Ultragenyx Pharmaceutical Inc. on Form 13F for the quarter ended 30 June 2026, against 298 the quarter before.
- Who is the largest institutional holder of Ultragenyx Pharmaceutical Inc.?
- BlackRock, Inc., with 10,654,276 shares worth $356 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Ultragenyx Pharmaceutical Inc. in Q2 2026?
- 59 managers reported a new position and 47 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Ultragenyx Pharmaceutical Inc., Q2 2026", https://app.tamarly.ai/holders/ultragenyx-pharmaceutical, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.